- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer Nos in United States
Total 31052 results
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer Metastatic | Targetable Oncogenes (EGFR, ALK, ROS1)United States
-
National Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)National Center for Complementary and Integrative Health (NCCIH); Radiation...CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Mirati Therapeutics Inc.RecruitingResectable Non-Small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingEarly Stage Non-Small Cell Lung CancerUnited States
-
BeiGeneActive, not recruitingNSCLC | Non-small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineCompletedOligometastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Varian, a Siemens Healthineers CompanyActive, not recruitingStage III Non-small Cell Lung CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)WithdrawnStage IIIA Non-Small Cell Lung CancerUnited States
-
University of California, DavisCompletedMETASTATIC NON-SMALL CELL LUNG CANCERUnited States
-
Theresa Whiteside, PhDImmune Cell Therapy Inc.TerminatedNon Small Cell Lung Cancer (NSCLC)United States
-
Brown UniversityBristol-Myers SquibbRecruitingNon Small Cell Lung CancerUnited States
-
University of RochesterRecruiting
-
Albert Einstein College of MedicineCelldex TherapeuticsTerminatedLung Cancer | Non Small Cell Lung CancerUnited States
-
Loyola UniversityActive, not recruitingNon Small Cell Lung CancerUnited States
-
The University of Texas Health Science Center at...Faron Pharmaceuticals LtdWithdrawnNon-small Cell Lung CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
Jonsson Comprehensive Cancer CenterTerminatedNon Small Cell Lung CancerUnited States
-
Clovis Oncology, Inc.Genentech, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Duke UniversitySanofiTerminatedNon-small Cell Lung CancerUnited States
-
NovaRx CorporationNo longer availableNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Georgetown UniversityRegeneron PharmaceuticalsNot yet recruitingNon-small Cell Lung Cancer Stage IIIUnited States
-
Regeneron PharmaceuticalsRecruiting
-
National Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
New Mexico Cancer Care AllianceUniversity of New Mexico Cancer Center; Lovelace Respiratory Research InstituteTerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung CancerUnited States
-
University of WashingtonAstraZenecaTerminatedStage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Locally Advanced Lung Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer | Malignant Pleural Effusion | Adenosquamous Cell Lung CancerUnited States
-
Emory UniversityBristol-Myers SquibbWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Greg Durm, MDAstraZeneca; Indiana University School of MedicineTerminatedNon Small Cell Lung Cancer | Stage III Non-small-cell Lung CancerUnited States
-
NYU Langone HealthRecruitingNon-small Cell Lung Cancer With STK11/LKB1 MutationUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaboratorsCompletedBronchioloalveolar Cell Variant of Non-small Cell Lung CancerUnited States
-
Indiana UniversityCompletedNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteTerminatedNon Small Cell Lung CancerUnited States
-
University of VirginiaNational Cancer Institute (NCI)Completed
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Georgetown UniversityGenentech, Inc.RecruitingNon-squamous Non-small-cell Lung CancerUnited States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
Yale UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; NextCure, Inc.RecruitingAdvanced Non-small Cell Lung CancerUnited States
-
Brown UniversityLifespanActive, not recruitingStage III Non-small-cell Lung CancerUnited States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedNon-Small Cell Lung Cancer (NSCLC)United States
-
Check, Jerome H., M.D., Ph.D.Corcept TherapeuticsTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
University of RochesterCelgene CorporationWithdrawnNon-small Cell Lung Cancer, Stage IIIUnited States
-
VA Office of Research and DevelopmentVA Greater Los Angeles Healthcare SystemNot yet recruitingEZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNon Small Cell Lung CancerUnited States
-
Cyclacel Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesTerminatedNon-small Cell Lung CancerUnited States
-
University of UtahBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States